Marshall Posner
MD
Professor of Medicine
👥Biography 个人简介
Marshall Posner co-led the TAX324 trial that established docetaxel-cisplatin-fluorouracil (TPF) induction chemotherapy for locally advanced HNSCC. This regimen transformed the induction chemotherapy paradigm and remains a milestone in head and neck cancer treatment. His career has spanned decades of clinical trial leadership in HNSCC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Marshall Posner 的研究动态
Follow Marshall Posner's research updates
留下邮箱，当我们发布与 Marshall Posner（Icahn School of Medicine at Mount Sinai）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment